INS and metabolic dysfunction-associated steatohepatitis: Because of the phenotypic similarities to the clinical features of human NASH, such as obesity (visceral fat accumulation) coupled with metabolic syndrome, insulin resistance, and adipokine imbalance, this DKO mouse represents a unique animal model for exploring novel therapeutic approaches for the prevention and/or treatment of NASH.